250 related articles for article (PubMed ID: 30740255)
1. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.
Yousaf AM; Malik UR; Shahzad Y; Mahmood T; Hussain T
J Pharm Anal; 2019 Feb; 9(1):34-39. PubMed ID: 30740255
[TBL] [Abstract][Full Text] [Related]
2. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
5. The preparation and physicochemical characterization of eprosartan mesylate-laden polymeric ternary solid dispersions for enhanced solubility and dissolution rate of the drug.
Yousaf AM; Zulfiqar S; Shahzad Y; Hussain T; Mahmood T; Jamshaid M
Polim Med; 2018; 48(2):69-75. PubMed ID: 30916494
[TBL] [Abstract][Full Text] [Related]
6. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
[TBL] [Abstract][Full Text] [Related]
7. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
Gorajana A; Rajendran A; Yew LM; Dua K
Int J Pharm Investig; 2015; 5(3):171-8. PubMed ID: 26258059
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
10. Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes.
Khan WH; Asghar S; Khan IU; Irfan M; Alshammari A; Riaz Rajoka MS; Munir R; Shah PA; Khalid I; Razzaq FA; Khalid SH
Heliyon; 2023 Sep; 9(9):e19658. PubMed ID: 37809727
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
12. Solid-state characterization of lacidipine/PVP K(29/32) solid dispersion primed by solvent co-evaporation.
Mukharya A; Chaudhary S; Mansuri N; Misra AK
Int J Pharm Investig; 2012 Apr; 2(2):90-6. PubMed ID: 23119238
[TBL] [Abstract][Full Text] [Related]
13. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
15. Solid Dispersion Approach Improving Dissolution Rate of Stiripentol: a Novel Antiepileptic Drug.
Afifi S
Iran J Pharm Res; 2015; 14(4):1001-14. PubMed ID: 26664367
[TBL] [Abstract][Full Text] [Related]
16. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
[TBL] [Abstract][Full Text] [Related]
17. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
[TBL] [Abstract][Full Text] [Related]
18. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
19. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.
Choi JS; Park JS
Eur J Pharm Sci; 2017 Jan; 97():269-276. PubMed ID: 27919702
[TBL] [Abstract][Full Text] [Related]
20. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
